Javascript must be enabled to continue!
Could Selective Calpain-2 Inhibitors be used for AD Treatment?
View through CrossRef
Work in our laboratory over the last 10 years has shown that prolonged brain calpain-2 activation following a variety of insults plays a critical role in brain pathology resulting from these insults, including neuronal damage, brain inflammation, and cognitive impairment. My laboratory is collaborating with NeurAegis, Inc, to develop selective calpain-2 inhibitors for the treatment of a number of neurological disorders, including traumatic brain injury and concussions. We have identified a lead clinical candidate, NA-184, which significantly inhibits neuronal damage in rodent models of TBI, as well as a blood biomarker, P13BP, which reflects brain calpain-2 activation. We will discuss our plans to bring NA-184 to the clinic in 2024.
International Association of Biomedical Sciences
Title: Could Selective Calpain-2 Inhibitors be used for AD Treatment?
Description:
Work in our laboratory over the last 10 years has shown that prolonged brain calpain-2 activation following a variety of insults plays a critical role in brain pathology resulting from these insults, including neuronal damage, brain inflammation, and cognitive impairment.
My laboratory is collaborating with NeurAegis, Inc, to develop selective calpain-2 inhibitors for the treatment of a number of neurological disorders, including traumatic brain injury and concussions.
We have identified a lead clinical candidate, NA-184, which significantly inhibits neuronal damage in rodent models of TBI, as well as a blood biomarker, P13BP, which reflects brain calpain-2 activation.
We will discuss our plans to bring NA-184 to the clinic in 2024.
Related Results
Differential Activation of Calpain-1 and Calpain-2 following Kainate-Induced Seizure Activity in Rats and Mice
Differential Activation of Calpain-1 and Calpain-2 following Kainate-Induced Seizure Activity in Rats and Mice
Systemic injection of kainate produces repetitive seizure activity in both rats and mice. It also results in short-term synaptic modifications as well as delayed neurodegeneration....
Calpain inhibition induces activation of the distinct signalling pathways and cell migration in human monocytes
Calpain inhibition induces activation of the distinct signalling pathways and cell migration in human monocytes
SummaryWe have recently reported that constitutively active calpain negatively regulates activation of the distinct signalling pathways and cell migration in human neutrophils. Her...
Calpain induces TNFα expression and cardiac dysfunction by IκB/NF-κB system in septic mice
Calpain induces TNFα expression and cardiac dysfunction by IκB/NF-κB system in septic mice
Objective
In septic models, recent studies showed that both myocardial calpain activity and TNFα expression increased, and inhibition of calpain downregulated myo...
Therapeutic potential of SGLT-2 inhibitors and DDP4 inhibitors in elderly patients with type 2 diabetes mellitus and benign prostatic hyperplasia
Therapeutic potential of SGLT-2 inhibitors and DDP4 inhibitors in elderly patients with type 2 diabetes mellitus and benign prostatic hyperplasia
Background. Benign prostatic hyperplasia (BPH) has recently been linked to diabetes mellitus and insulin resistance. This study aims to explore whether the use of either sodium-glu...
Insights into the mechanisms underlying calpain-related pathology
Insights into the mechanisms underlying calpain-related pathology
The molecular interactions underlying vitreoretinopathy are poorly understood. Mutations in calpain-5 (CAPN5) were identified as the cause of autosomal dominant neovascular inflamm...
Neuroprotection mediated by inhibition of calpain during acute viral encephalitis
Neuroprotection mediated by inhibition of calpain during acute viral encephalitis
AbstractNeurologic complications associated with viral encephalitis, including seizures and cognitive impairment, are a global health issue, especially in children. We previously s...
HERG1 Expression Increases Calpain Activity in C2C12 Myotubes
HERG1 Expression Increases Calpain Activity in C2C12 Myotubes
Skeletal muscle atrophy is the loss of muscle size and strength caused by an imbalance in protein degradation and protein synthesis. It occurs with normal aging, neural and skeleta...
Anti-Tumor Activity of Immunoproteasome Selective Inhibitors.
Anti-Tumor Activity of Immunoproteasome Selective Inhibitors.
Abstract
Background: The immunoproteasome is a form of the proteasome that is distinct from the broadly expressed constitutive proteasome. The immunoproteasome, whic...

